Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.24.2
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
External research and preclinical development $ 9,117 $ 8,001
Employee compensation and benefits 3,815 6,993
Professional fees 983 1,015
Facilities and other 642 137
Accrued expenses $ 14,557 $ 16,146